Related Experiment Video

Updated: Aug 13, 2026

Protocols for Testing the Toxicity of Novel Insecticidal Chemistries to Mosquitoes
09:32

Protocols for Testing the Toxicity of Novel Insecticidal Chemistries to Mosquitoes

Published on: February 13, 2019

Mutagenic potential of 4 organophosphinate compounds

N R Powers, P P Waring, C N Lieske

    Toxicology Letters
    |October 1, 1984
    PubMed

    Insights

    Four organophosphinate compounds were tested for mutagenicity using the sex-linked recessive lethal assay. Results showed no significant mutagenic activity, indicating these compounds are non-mutagenic and safe for further research.

    Area of Science:

    • Toxicology
    • Genetics

    Background:

    • Organophosphinate compounds are being studied for their potential to prevent anticholinesterase poisoning.
    • Assessing the mutagenicity of these compounds is crucial for evaluating their safety.
    • The sex-linked recessive lethal (SLRL) assay is a standard method for detecting mutations.

    Purpose of the Study:

    • To evaluate the mutation frequency of four organophosphinate compounds at various concentrations.
    • To determine the potential mutagenic effects of these compounds using the SLRL assay.

    Main Methods:

    • The sex-linked recessive lethal (SLRL) assay was employed to assess mutation frequency.
    • Four organophosphinate compounds were tested at different concentrations.
    • Fisher's Exact Test was used for statistical analysis, comparing results to negative controls.

    Main Results:

    • No significant differences in mutation frequency (P > 0.05) were observed for any of the four compounds at the tested concentrations.
    • Specifically, 4-nitrophenyl methyl (phenyl) phosphinate, 4-nitrophenyl monochloromethyl (phenyl) phosphinate, 4-nitrophenyl diphenyl phosphinate, and 4-nitrophenyl dimethyl phosphinate showed non-mutagenic activity.
    • These findings align with previous research using the Ames assay, confirming the non-mutagenic nature of these compounds.

    Conclusions:

    • The investigated organophosphinate compounds do not exhibit mutagenic activity in the SLRL assay.
    • The results support the safety profile of these compounds for potential use in prophylactic treatments against anticholinesterase poisoning.

    More Related Videos

    Analysis of Organochlorine Pesticides in a Soil Sample by a Modified QuEChERS Approach Using Ammonium Formate04:17

    Analysis of Organochlorine Pesticides in a Soil Sample by a Modified QuEChERS Approach Using Ammonium Formate

    Published on: January 20, 2023

    Assessing Cytotoxicity of Metabolites of Typical Triazole Pesticides in Plants08:22

    Assessing Cytotoxicity of Metabolites of Typical Triazole Pesticides in Plants

    Published on: December 22, 2023

    Related Concept Videos

    Physical Properties of Amines01:26

    Physical Properties of Amines

    Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
    Mutagenicity and Carcinogenicity01:25

    Mutagenicity and Carcinogenicity

    Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
    Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

    Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

    Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
    Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
    Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

    Indirect-Acting Cholinergic Agonists: Mechanism of Action

    Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
    Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
    Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

    Indirect-Acting Cholinergic Agonists: Pharmacokinetics

    Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
    Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
    Anticholinesterase Agents: Poisoning and Treatment01:26

    Anticholinesterase Agents: Poisoning and Treatment

    Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
    Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...